LobbyingAim Immunotech lobbying by quarter
Aim Immunotech AIM's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Pharmacy.
Aim ImmunotechAIM
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $80K | 2 |
| Q1 2023 | $80K | 2 |
| Q2 2023 | $80K | 2 |
| Q3 2023 | $80K | 2 |
| Q4 2023 | $80K | 2 |
| Q1 2024 | $20K | 2 |
| Q2 2024 | $20K | 2 |
| Q3 2024 | $20K | 1 |
| Q4 2024 | $20K | 1 |
| Q1 2025 | $20K | 1 |
| Q2 2025 | $20K | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$270K · 16 reports
- Pharmacy$110K · 11 reports
- Budget and appropriations$100K · 4 reports
- Financial institutions and securities$40K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Defense, Dept of (DOD)11 reports
- Natl Institutes of Health (NIH)7 reports
- Food & Drug Administration (FDA)1 reports
- Navy, Dept of1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Podesta.com | $300K | 7 quarters |
| Buchanan Ingersoll & Rooney PC | $220K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| EDWARD HILD | Chief of Staff, Sen. Lisa Murkowski; Deputy Chief of Staff, Sen. Pete Domenici | Q2 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Buchanan Ingersoll & Rooney PC | Under $5,000 |
| 04/20for Q1 | Buchanan Ingersoll & Rooney PC | Under $5,000 |
| 01/20for Q4 2025 | Buchanan Ingersoll & Rooney PC | Under $5,000 |
| 25/10/15for Q3 2025 | Buchanan Ingersoll & Rooney PC | Under $5,000 |
| 25/07/17for Q2 2025 | Buchanan Ingersoll & Rooney PC | $20K |
| 25/04/02for Q1 2025 | Buchanan Ingersoll & Rooney PC | $20K |
| 25/01/16for Q4 2024 | Buchanan Ingersoll & Rooney PC | $20K |
| 24/10/10for Q3 2024 | Buchanan Ingersoll & Rooney PC | $20K |
| 24/07/16for Q2 2024 | Buchanan Ingersoll & Rooney PC | $20K |
| 24/07/09for Q2 2024 | Podesta.com | Under $5,000 |
| 24/04/18for Q1 2024 | Buchanan Ingersoll & Rooney PC | $20K |
| 24/04/01for Q1 2024 | Podesta.com | Under $5,000 |
| 24/01/22for Q4 2023 | Buchanan Ingersoll & Rooney PC | $20K |
| 23/12/27for Q4 2023 | Podesta.com | $60K |
| 23/10/20for Q3 2023 | Podesta.com | $60K |
| 23/10/20for Q2 2023 | Podesta.com | $60K |
| 23/10/17for Q3 2023 | Buchanan Ingersoll & Rooney PC | $20K |
| 23/07/19for Q2 2023 | Podesta.com | $60K |
| 23/07/18for Q2 2023 | Buchanan Ingersoll & Rooney PC | $20K |
| 23/04/20for Q1 2023 | Podesta.com | $60K |